s many as 4,100 children were born with major birth defects due to a Sanofi epilepsy drug that was taken by women who were being treated for epilepsy or bipolar disorder, according to a report by the ANSM, the French National Agency for Medicines and Health Products Safety.

Between 1967 and 2016, anywhere from 2,150 to 4,100 children were born with at least one major congenital disorder after being exposed to valproate, which is known as Depakote for treating bipolar disorder and Depakine for treating epilepsy. During that time, between 64,100 and 100,000 pregnancies in France were exposed to the medicine.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

    • Actually the drug was discovered by French scientists and is marketed in US by Abbott and by Sanofi ex US. You can tell which version is which by the spelling. It is spelled Depakene in the US, and as Depakine ex US.

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.